October 2, 2018 Clinical Research/Diagn. Lab Top-10 Life Science Tools M&A, Partnerships

Seoul St. Mary's Hospital and Singapore General Hospital Join Thermo Fisher Scientific's Next-Generation Sequencing Center of Excellence Program

Seoul St. Mary’s Hospital and Singapore General Hospital Join Thermo Fisher Scientific’s Next-Generation Sequencing Center of Excellence Program Newest partners announced during company’s Global Strategic Partner Summit in Boston BOSTON, Oct. 2, 2018 /PRNewswire/ — Seoul St. Mary’s Hospital, part of Catholic Medical Center (CMC) in South Korea, and Singapore General Hospital are the newest... Read more

September 27, 2018 Clinical Research/Diagn. Informatics & Software Life Science Tools M&A, Partnerships

Baylor-Hopkins Clinical Genome Center (BHCGC) Announces Major Role in National Institutes of Health Precision Medicine Research Effort

DNAnexus selected by BHCGC to serve as its primary portal for communication and data sharing with the All of Us Research Program. September 27, 2018 08:00 AM Eastern Daylight Time MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–The Baylor College of Medicine Human Genome Sequencing Center (HGSC) today announced participation in the National Institutes of Health All of Us Research Program, a large-scale effort to advance... Read more

September 26, 2018 Life Science Tools M&A, Partnerships

Brooks Automation Announces the Acquisition of GENEWIZ Group

CHELMSFORD, Mass., Sept. 26, 2018 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) today announced that it has entered into a definitive agreement to acquire GENEWIZ Group, a leading global genomics service provider headquartered in South Plainfield, New Jersey.  The total cash purchase price for the acquisition will be approximately $450 million, subject to working capital and... Read more

September 26, 2018 Life Science Tools M&A, Partnerships

GENEWIZ to Be Acquired by Brooks Automation

SOUTH PLAINFIELD, NJ, September 26, 2018 — GENEWIZ announced today that it has entered into a definitive agreement to be acquired by Brooks Automation, Inc. GENEWIZ is a leading global genomics service provider with laboratory operations in the United States, the United Kingdom, Germany, China, and Japan. Brooks Automation is a worldwide provider of automation solutions... Read more

September 25, 2018 Clinical Research/Diagn. Lab Top-10 Life Science Tools

Game Changing Tuberculosis Assay Validated for Illumina’s MiSeq® Platform

Next Generation Sequencing (NGS) Kit to Improve Speed and Accuracy of M. Tuberculosis (MTB) Drug Sensitivity Testing (DST) at a Fraction of the Current Cost of Sequencing BETHESDA, Maryland, Sept. 25, 2018 /PRNewswire/ — Longhorn Vaccines and Diagnostics LLC (LHNVD), a private pre-analytical systems and molecular solutions company, is pleased to announce the validation of its newest technology,... Read more

September 23, 2018 Life Science Tools M&A, Partnerships

Tecan successfully completes the acquisition of NuGEN Technologies

Männedorf, Switzerland, September 3, 2018 – The Tecan Group (SIX Swiss Exchange: TECN) announced today that it has successfully completed the acquisition of NuGEN Technologies, Inc. (NuGEN) on August 31, 2018. On August 16, 2018, Tecan announced the acquisition of US-based NuGEN to further expand Tecan’s dedicated solutions offering into the new market segment of next-generation... Read more

September 20, 2018 Informatics & Software Life Science Tools Product Launch

Paragon Genomics Launches ParagonDesigner™ Online Tool That Makes It Easy To Design Custom CleanPlex® NGS Assays

  –Custom NGS Panels for Illumina and Ion Torrent Platforms Use Paragon Genomics’ CleanPlex® Technology that Enables Interrogation of a Large Number of Targets in a Single Assay– –Complementary Expert Support Is Available to All Customers and Custom NGS Panels are Delivered in Just 2-4 Weeks– HAYWARD, Calif., Sept. 20, 2018 /PRNewswire/ — Paragon Genomics, Inc. today... Read more

September 18, 2018 Lab Top-10 Licensing, IP, and Legal Life Science Tools

Twist Bioscience Responds to Agilent’s Latest Specious Claims

Download PDF SAN FRANCISCO, Calif. – September 18, 2018 — Twist Bioscience issued the following statement: Agilent’s wholesale shift in its allegations, two and a half years into its suit, reveals only the weakness of its claims. Agilent’s most recent allegations are gamesmanship, not substance. They omit that more than four months before it sought to change its... Read more

September 18, 2018 Licensing, IP, and Legal Life Science Tools

SomaGenics’ Strengthens Its IP and Technology Position in Small RNA Analysis and Biomarker Discovery With New Patent and Publication

SANTA CRUZ, Calif., Sept. 18, 2018 /PRNewswire/ — SomaGenics, a biotechnology company focused on developing lowest bias sequencing and highest specificity RT-qPCR technologies for small RNAs, announced today the issue of US Patent 10,041,107, a continuation of SomaGenics’ patent family entitled “Methods and Compositions for Detection of small RNAs.” The new patent broads protection for SomaGenics’ innovative,... Read more

September 18, 2018 Lab Top-10 Licensing, IP, and Legal Life Science Tools

Thermo Fisher Scientific Expands Genome Editing IP Portfolio

New license agreements for CRISPR technology from Broad Institute and ERS Genomics extend industry-leading genome editing capabilities CARLSBAD, Calif., Sept. 18, 2018 /PRNewswire/ — Thermo Fisher Scientific, Inc., the world leader in serving science, has licensed CRISPR technologies from the Broad Institute and ERS Genomics (foundational University of California IP) to bolster its genome editing... Read more